Search

Search Results

• Once-daily intravenous busulfan as myeloablative, reduced-toxicity conditioning regimen: results in young and adult patients with hematological malignant and nonmalignant diseases

  E Di Bartolomeo, S Santarone, P Bavaro, P Di Carlo, P Olioso, G Papalinetti, P Di Bartolomeo

  2009-06-23

  https://doi.org/10.4081/hmr.v2i6.771

  322

  PDF: 952

• 7TH HEREDITARY HEMORRHAGIC TELANGIECTASIA INTERNATIONAL SCIENTIFIC CONFERENCE

  Carlo Sabbà

  2009-06-16

  https://doi.org/10.4081/hmr.v1i1.617

  206

  PDF: 365

  PDF: 351

  PDF: 120

  PDF: 225